Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04710004 · ClinicalTrials.gov registry record · NA

Electrophysiological Biomarkers in MTLE Patients.

A NA study, sponsored by Emory University.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT04710004: Clinical Trial NA study, sponsored by Emory University.

NCT04710004 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04710004, a NA study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

Primary Outcome

Spectral power will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates spectral power during the preictal, ictal or post ictal states. Spectral power is measured in microvolts. A change in either direction from baseline is associated with a better outcome.

Interventions

  • DEVICE Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2021-11-30
Est. Completion 2021-12-16
Phase NA
Emory University

1,208 total trials

Why NCT04710004 stopped before completion

NCT04710004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device is the first listed.

NCT04710004 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04710004 about?

NCT04710004 is a clinical study titled "Electrophysiological Biomarkers in MTLE Patients.". The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monito...

What is the current status of trial NCT04710004?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-11-30. Estimated completion is 2021-12-16.

What interventions are being tested in trial NCT04710004?

The interventions under investigation include: Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device (DEVICE).

Who is sponsoring clinical trial NCT04710004?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04710004's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04710004, the US trial registry maintained by the National Library of Medicine. NCT04710004 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.